Do Digestive Enzymes Actually Work for FODMAPs? An Honest Look at the Evidence

Written by Julian Meer, founder of Fodease. Scientifically reviewed by Allegra Aron, PhD, University of Denver.

You’ve probably been told that a FODMAP enzyme lets you eat anything. That’s not quite true, and knowing why will help you get a lot more out of one. Here’s the short answer first, then the evidence.

Yes, digestive enzymes can target and break down specific FODMAP groups (namely lactose, GOS, and fructans) before they undergo bacterial fermentation in the gut. They cannot address polyols (no oral supplement available today breaks them down) or excess fructose in an uncoated sprinkle-on-food powder (the enzyme for it, xylose isomerase, works only when protected from stomach acid by an enteric coating, a capsule, or both). Overall efficacy depends entirely on matching the correct enzyme to its specific carbohydrate substrate, in the right delivery format, at a transparent, clinically meaningful dose.

The FODMAP Enzyme Efficacy Matrix

FODMAP Subgroup	Common Food Sources	Target Enzyme	Clinical Evidence Level & Action
Lactose	Milk, ice cream, soft cheeses, yogurt	Lactase	High: Decades of independent human clinical trials establish it hydrolyzes lactose in the digestive tract (Baijal and Tandon 2021; Booster Alpha/Omega trials).
GOS (Galacto-oligosaccharides)	Beans, lentils, chickpeas, cashews	Alpha-Galactosidase	Moderate to High: Strong randomized controlled trial (RCT) evidence for GOS-rich meals at adequate dose; no benefit when used as a general irritable bowel syndrome (IBS) treatment (Di Stefano 2007; Tuck 2018; null results Hillila 2016, Bohn 2021).
Fructans	Garlic, onions, wheat, leeks, inulin	Inulinase (also sold as fructan hydrolase)	Emerging / Mechanistically Sound: Real published degradation data (in-vitro plus early human cohort); newest of the three (Castro Ochoa 2023; Guice 2023; Kaye 2026).
Polyols (Sorbitol & Mannitol)	Avocados, mushrooms, stone fruits	None currently available in any product	None: The enzyme the body uses needs NAD+ cofactor recycling that doesn't exist on a plate, and no food-grade alternative has been developed (StatPearls, polyol pathway; Forneris 2008).
Excess Fructose	Honey, apples, pears, HFCS	Xylose isomerase (needs acid protection, not an uncoated powder)	Effective enzyme exists, needs the right format: Xylose isomerase has human RCT support but must be protected from stomach acid (enteric coating, capsule, or both). Cannot work as an uncoated sprinkle-on-food powder.

How FODMAP Enzymes Actually Work

Your gut doesn't struggle to break down FODMAPs because of acid or a weak stomach. It struggles because of a specific biochemical mismatch: your small intestine doesn't produce the enzymes needed to break certain carbohydrates apart. Those intact carbohydrates travel to your large intestine, where gut bacteria ferment them. That fermentation produces gas, draws water into the intestine, and creates the bloating, distension, and discomfort you already know.

Why your gut lacks these enzymes in the first place.

This is worth separating out, because the answer is different for each FODMAP group and it changes how you should think about the whole category.

For fructans and GOS, nobody has the enzyme. No human produces anything that breaks the bonds in a fructan chain or the galactose links in GOS (Gibson and Shepherd 2010; Barrett 2010). That is not a deficiency or a defect, it is the human baseline. Everyone who eats garlic or beans sends those carbohydrates to the colon intact. Your gut bacteria, on the other hand, do carry those enzymes, which is precisely why fermentation happens down there. They digest what you cannot, and gas is the byproduct. What differs between people is not a missing enzyme, it is how much gas their particular microbiome produces from the same food and how sensitive their gut is to the result.

Lactose is the exception, and it is genetic. Humans do make lactase, at full strength in infancy. In roughly two thirds of the world’s adults, that production falls off sharply after weaning (Anguita-Ruiz 2020). The trait that keeps it switched on through adulthood, called lactase persistence, comes from regulatory variants near the lactase gene and is common in populations with a long history of dairy herding and rare elsewhere. Declining lactase is the ancestral human default, not the abnormality (Itan 2009).

So a FODMAP enzyme supplement is not replacing something your body lost. For fructans and GOS it adds a capability humans never had, borrowed from the fungi and bacteria that do produce these enzymes and are the commercial source of food-grade versions. For lactose it tops up something most adults stop making.

A FODMAP enzyme works by doing the job your small intestine can't. Sprinkled onto food, it breaks the specific chemical bonds holding a FODMAP together, before that food reaches the colon. The carbohydrate gets cleaved into smaller sugars your body absorbs normally. No intact FODMAP reaching the bacteria means less substrate to ferment, which means less gas produced downstream.

The critical word is specific. Each enzyme breaks one particular linkage in one particular substrate, not a category of bond in general. Lactase cleaves the bond joining galactose to glucose in lactose. Alpha-galactosidase cleaves the alpha-galactose links in GOS. Inulinase cleaves the beta-2,1 fructose links in a fructan chain. All three of those are glycosidic bonds, but the enzymes are not interchangeable, because each one recognizes the shape of its own substrate rather than the bond type alone. An enzyme that targets lactose does nothing for the fructans in garlic, and vice versa. This is the single most important thing to understand about this category, and the reason the next point matters so much: a product only works on a given FODMAP if it actually contains the right enzyme, at a high enough activity level to do meaningful work on a real plate of food. Coverage and dose are everything. An enzyme that isn't in the jar, or is present only in a token amount, is not protecting you, no matter what the front of the label implies.

This is also why no single enzyme, and no honest single product, can claim to handle all five FODMAP groups. The biology doesn't allow one key to open five different locks. Which brings us to the part of this conversation most product pages skip entirely.

The Evidence, Enzyme by Enzyme

"Do enzymes work" is the wrong question. The right question is "which enzyme, for which FODMAP, backed by what kind of evidence?" Because the answer changes group by group. Some of these enzymes have decades of independent human research behind them. Others have promising but newer data. Treating them as one undifferentiated category, the way most marketing does, hides exactly the information you need to make a good decision. So here's the honest breakdown, strongest evidence first.

A note on what "evidence" means here, because not all studies carry equal weight. The gold standard is the independent, randomized, placebo-controlled human trial: real people, controlled conditions, no financial stake in the outcome. Below that sits human cohort and observational data. Below that, in-vitro studies: experiments in simulated gut models, genuinely useful for showing an enzyme can break a bond, but can't tell you how it'll perform in a living person. And industry-funded studies, common and not inherently invalid, still warrant a closer look than independent ones. We'll tell you which tier each enzyme's evidence sits in. That transparency is the whole point.

Lactase (for lactose) — the strongest evidence

Targets: lactose, the sugar in milk, soft cheese, yogurt, and ice cream.

What the research shows: This is the most-studied enzyme supplement in the entire category, and the evidence is strong and independent. In a randomized, double-blind, placebo-controlled crossover trial, adults with diagnosed lactose intolerance had significantly lower symptom scores and significantly lower hydrogen breath levels (an objective marker of lactose fermentation) when they took lactase versus placebo.¹ Separate registered clinical trials have found lactase reduces breath hydrogen and lowers the odds of abdominal pain and flatulence after a lactose challenge.² This isn't emerging or simulated, it's decades of human data.

Breath hydrogen is worth explaining, because it comes up throughout this article. When gut bacteria ferment a carbohydrate you did not digest, hydrogen gas is one of the byproducts. Some of that hydrogen crosses into the bloodstream and leaves through the lungs, where it can be measured in a breath sample. Less breath hydrogen means less fermentation took place. That makes it an objective measurement of what happened in the gut rather than a self-reported impression of how someone felt, which is why researchers lean on it.

The honest read on the evidence: This is as settled as enzyme supplementation gets. Lactase sits at the top of the evidence hierarchy: independent, randomized, placebo-controlled, human, with both symptom and objective biomarker improvements. If you're lactose intolerant, the science that supplemental lactase helps break down lactose is about as solid as it gets in this space.

What this means for choosing a product: Even with the best-supported enzyme, dose still decides outcome. Lactase activity is measured in FCC units (ALU on some labels), and the amount matters; a product listing "lactase" with no activity number is asking you to trust rather than verify. The enzyme works; the question is whether you're getting enough of it.

Alpha-galactosidase (for GOS) — strong for the right food, at the right dose

Targets: GOS (galacto-oligosaccharides), the FODMAP in beans, lentils, chickpeas, and cashews.

What the research shows: Alpha-galactosidase has solid human-trial support, with an important pattern in the data. In a randomized, double-blind, placebo-controlled study, healthy volunteers ate a heavy 420g bean meal (rich in GOS) with either 300 GalU, 1,200 GalU, or placebo. The 1,200 GalU dose produced a significant reduction in both breath hydrogen (an objective marker of fermentation) and flatulence. The lower 300 GalU dose helped less; the effect was dose-dependent.³ Other controlled work has found that the increase in symptoms specifically triggered by GOS ingestion is mitigated by alpha-galactosidase.⁴

The honest read on the evidence, including where it fails: Here's the part most sellers leave out. When alpha-galactosidase is tested as a general treatment for IBS, given to a broad group of IBS patients without isolating whether they're actually eating GOS, the benefit tends to disappear. A placebo-controlled pilot in IBS patients found it was not superior to placebo for reducing postprandial gas or symptoms, and a separate general-IBS trial found the same.^{5, 6} This isn't evidence that the enzyme doesn't work. It's evidence that it's a targeted tool, not a cure-all: it reduces gas from GOS-containing foods when dosed adequately, and it does nothing for symptoms that aren't being driven by GOS in the first place. Match it to the food and the dose, and the data supports it. Treat it as a blanket fix for "IBS," and it underdelivers, because that was never what it does.

What this means for choosing a product: Two numbers decide whether this enzyme helps: the activity dose (the bean study needed 1,200 GalU to move breath hydrogen, not a token amount) and whether you're using it on the right FODMAP. A product that hides its alpha-galactosidase inside a "proprietary blend" with no GalU figure gives you no way to know if you're getting a clinically meaningful dose or a sprinkle for show. The research says dose is the difference between working and not. The label should let you check it.

Inulinase (for fructans) — emerging but real

Targets: fructans, the FODMAP in garlic, onion, wheat, and leeks. The hardest group for most people to avoid, because garlic and onion are in nearly everything.

What the research shows: Of the three enzymes in most FODMAP blends, fructan-targeting enzymes are the newest to the category but now have real published data behind them. The most-cited work is an in-vitro study using a multi-compartment simulation of the human gut, which found that a fructan enzyme blend degraded roughly 90% of inulin (a common fructan) within 30 minutes, while largely preserving the beneficial short-chain fatty acid production a strict low-FODMAP diet can deplete.⁷ A separate 2023 in-vitro study, run by an enzyme ingredient supplier rather than a finished-product brand, tested a microbial inulinase on purified inulin, garlic, and a high-fructan meal under simulated stomach conditions. Doses from 50 up to 800 INU per serving broke down more fructan than no enzyme at all (Guice 2023).⁸ More recently, human cohort data has begun to appear as well.⁹

The honest read on the evidence: This is genuine, peer-reviewed science, and it's a meaningful signal that the enzyme does what it's supposed to. Two fair caveats keep it in perspective. The headline data is in-vitro (a simulated gut, not a living one), so it shows the enzyme can break fructans down under modeled conditions, which is not the same as a large independent human trial. And much of the existing finished-product research has been funded by the companies selling the products, which is common in this young category and doesn't invalidate the work, but is worth knowing. So, fructan enzymes are mechanistically sound, supported by published degradation data, and best described as emerging but real, not unproven, and not yet backed by the kind of large independent human RCT that lactase enjoys.

A note on names: inulinase vs. fructan hydrolase. You’ll see fructan enzymes labeled both ways, sometimes for the same enzyme. “Fructan hydrolase” is the broad family name for any enzyme that splits fructans. Inulinase is the member that targets the beta-2,1 bonds that make up inulin-type fructans, the kind in garlic and onion. Wheat fructans are more mixed, with an extra beta-2,6 bond type that inulinase-type enzymes break only partially. Some products describe their enzyme as a broad-spectrum fructan hydrolase that reaches more of those bonds. That may be true, but no independent head-to-head data on wheat has been published yet, so treat the name on a label as a description, not proof of broader coverage.

What this means for choosing a product: Because the enzyme is real but the category is young, the variable that matters most is how much active enzyme you're actually getting. A fructan enzyme at a token dose is theater. This is where published activity units, measured in INU for inulinase, separate a product you can evaluate from one you have to take on faith.

The Deep Biochemistry: Why Some FODMAPs Can't Be Solved With a Powder

This is the part almost no product page will explain, because explaining it means admitting limits. But it's also the part that, once you understand it, tells you more about which enzyme products are honest than any marketing claim ever could. So here's the actual chemistry.

Two kinds of enzymes, and only one of them works on your plate.

The enzymes that successfully break down lactose, GOS, and fructans (lactase, alpha-galactosidase, inulinase) all belong to a family called hydrolases. Hydrolases do one simple thing: they use water to split a chemical bond. That's it. Sprinkle one on moist food and it goes to work immediately, because food supplies the only thing it needs, water. This is why these three FODMAPs are solvable with a powder.

Polyols and excess fructose are handled by a completely different class of enzyme, and that difference is the whole problem.

Polyols: the cofactor problem.

To break down a polyol like sorbitol or mannitol, the body doesn't use a hydrolase. It uses a dehydrogenase, specifically sorbitol dehydrogenase (and mannitol dehydrogenase for mannitol). These enzymes don't split a bond with water. They run an oxidation reaction: they convert sorbitol into fructose, and to do it, they require a helper molecule called NAD+.¹⁰

Here's why that one detail is fatal for a powder. NAD+ isn't part of the enzyme, it's a separate molecule the enzyme consumes during the reaction, converting it to a spent form called NADH. The reaction is, precisely: sorbitol + NAD+ → fructose + NADH. So for a dehydrogenase to keep working, it needs a continuous supply of fresh NAD+ and a system to recycle the spent NADH back into NAD+. Your cells have exactly that machinery, an entire metabolic apparatus dedicated to keeping NAD+ available. A spoonful of enzyme powder sitting on your pasta does not. There's no NAD+ on the plate, and nothing to regenerate it. The enzyme would run its reaction once, consume whatever tiny amount of cofactor happened to be nearby, and stop. Dead in one turn.

That rules out the enzyme your body uses. It doesn't rule out every enzyme. Some soil bacteria make a different kind, an alditol oxidase, that can attack sorbitol and mannitol without NAD+, using a cofactor permanently bound to the enzyme and recharged by oxygen. But it needs oxygen to keep working, produces hydrogen peroxide as a byproduct, and nobody has turned it into a safe, food-grade supplement. So a polyol enzyme isn't impossible in principle. It just doesn't exist as a product today, which is why no enzyme supplement on the market, ours included, meaningfully handles polyols, and why you should be skeptical of any that claims to.

Excess fructose: the delivery problem (and why it can be solved, just not without protecting the enzyme).

Excess fructose is different from polyols in an important way: there is an enzyme that breaks it down effectively. That enzyme is xylose isomerase, and it has genuine human evidence behind it. In a double-blind, placebo-controlled study, orally administered xylose isomerase reduced breath hydrogen and improved GI symptoms in people with fructose malabsorption.¹¹ So unlike polyols, this isn't a dead end. The enzyme works.

The obstacle is acid protection, not the enzyme. Xylose isomerase needs a near-neutral to slightly alkaline pH to function, and your stomach is strongly acidic, roughly pH 1.5 to 3.5 during digestion. An enzyme that hits stomach acid unprotected has its activity disrupted before it can do meaningful work. This is exactly why the xylose isomerase products that do work shield the enzyme from acid: the active particles carry an enteric (acid-resistant) coating, are enclosed in a capsule, or both. The protection is engineered to survive the stomach and release the enzyme further down, where the pH is right. With that protection, the enzyme does its job; without it, the delivery fails before the enzyme gets a chance.

The obvious question is whether you could engineer or evolve an acid-stable version of the enzyme instead and skip the coating altogether. In principle yes, and protein engineering for pH tolerance is an active research area. Nothing commercially available works that way today, so for now the answer to stomach acid is physical protection rather than a tougher enzyme.

That's the real reason excess fructose can't be addressed by a product like this one. It isn't that powder as a format can't carry xylose isomerase (enteric-coated enzyme particles can absolutely be a powder). It's that an uncoated powder you stir straight into your meal gives the enzyme no acid protection at all. Solving excess fructose properly means an acid-protected delivery: enteric-coated enzyme, a capsule, or both, which is a fundamentally different product from a bare powder you sprinkle onto food. That's a real and legitimate approach, just a separate format from the one you stir into your dinner.

Why this matters for choosing a product.

Put the two facts together and you get a simple test for honesty. Three FODMAP groups (lactose, GOS, fructans) are addressable by hydrolases, which work fine in a powder. The other two are not, for different reasons. Polyols have no enzyme supplement today. The dehydrogenase the body uses needs a cofactor-recycling system that doesn't exist outside a living cell, and the bacterial alternatives haven't been made into a food-grade product. Excess fructose does have a working enzyme (xylose isomerase), but it only works when protected from stomach acid (an enteric coating on the enzyme, a capsule, or both), never as an uncoated powder you stir into food. So any product claiming a single scoop of uncoated powder neutralizes all five FODMAP groups is, charitably, overselling, and less charitably, counting on you not knowing the chemistry. Now you know it. A powder that's honest about covering three groups, and clear about why the other two need either a different enzyme reality (polyols) or a different delivery format (fructose), is telling you the truth about what a sprinkle can do. That honesty is rarer than it should be, and it's worth looking for.

Why Dose and Transparency Decide Whether an Enzyme Works

By now one word has come up in every part of this article: dose. It's not an accident. The single most important thing the research shows, across every enzyme, is that an enzyme only works if you get enough of it for the food on your plate. A clinically valid enzyme at a token amount does roughly nothing.

This is the gap between "contains lactase" and "contains enough lactase to handle your latte." Both are technically true statements a label can make. Only one of them helps you.

Enzyme strength isn't measured in milligrams. Milligrams tell you the weight of the powder, not how much work it can do, and two products with identical milligrams can differ enormously in actual activity. Strength is measured in activity units, and each enzyme has its own: FCC (or ALU) for lactase, GalU for alpha-galactosidase, INU for inulinase. These units measure how much substrate the enzyme can actually break down. They are the only honest way to compare two products, and the only way to check a dose against what the research used.

Which is exactly why some products don't show them.

When a label lists a "proprietary blend, 300 mg" instead of the activity units of each enzyme, you cannot tell what you're getting. You don't know how much of each enzyme is in the blend, or whether any of them are dosed high enough to matter. The 300 mg could be mostly filler with a sprinkle of active enzyme, and you'd never know. "Proprietary blend" can be a legitimate way to protect a recipe, but in the enzyme world it most often protects the one thing you most need to see: whether the dose is real. The bean study earlier needed a specific, disclosed activity level to move the needle. You cannot do that math on a blend that hides the numbers.

So the rule that falls out of all the science is simple: a product that publishes its activity units is one you can evaluate. A product that doesn't is one you have to trust blindly. In a category where dose is the whole game, that difference is everything.

How to Evaluate Any FODMAP Enzyme Product

Here's a practical checklist you can use on any enzyme product, including the ones we don't make. If a product passes these, it's being honest with you. If it doesn't, ask why.

1. Does it publish activity units, not just milligrams? Look for FCC/ALU (lactase), GalU (alpha-galactosidase), and INU (inulinase), not just a total milligram weight. Units tell you how much work the enzyme can do. Milligrams alone don't. If you only see milligrams, or a single blended weight, you can't assess the dose.
2. Is each enzyme listed individually, or hidden in a "proprietary blend"? A blend that gives one combined number for several enzymes hides the per-enzyme dose. You want each enzyme broken out with its own activity figure.
3. Does it match its coverage to its claims, honestly? Which FODMAP groups does it actually contain enzymes for? And does it claim more than that? A product with lactase, alpha-galactosidase, and inulinase covers lactose, GOS, and fructans, that's a legitimate, science-supported scope. A product claiming to handle all five groups, including polyols and excess fructose, is claiming something the chemistry doesn't currently support.
4. Does the dose look meaningful for a real meal? Once units are disclosed, you can sanity-check them against your own portions and against published research. A token dose of a real enzyme is still a token dose.
5. Is it tested, and will they say so plainly? Look for batch testing for potency and contaminants. A company confident in its product will state this clearly rather than burying it.

Run any product, any brand, through those five. The honest ones welcome the scrutiny. The ones counting on you not to look are the ones to be careful with.

---

Where We Stand

Transparency disclosure: We make a FODMAP enzyme product called Fodease, so we're not a neutral party, and we'd rather say that outright than pretend otherwise. Everything above is true regardless of what we sell. But you should know who's writing it.

We built Fodease around the exact checklist you just read, because that checklist is the product we wished existed when we were the ones standing in the kitchen reading labels. We publish every enzyme's activity units on the jar (FCC, GalU, INU) with no proprietary blend. We cover the three FODMAP groups a powder can genuinely address (lactose, GOS, and fructans) and we tell you plainly what this powder doesn't: polyols, which no oral supplement available today breaks down, and excess fructose, which needs an acid-protected delivery rather than a sprinkle, something a powder you stir into food can't provide. We'd rather be clear about the edges of what we make than imply one scoop does everything. Our heavy metals testing is done by an independent ISO 17025 lab, and the results are posted on our testing page. We haven't run third-party potency testing yet, and when we do, we'll publish that too.

That's the whole pitch, and it's the same standard we just asked you to hold everyone to. If you want to see how we measure up against your own checklist, the product's right here. And if you take this article and go buy a competitor's product because it passed the same test, we're genuinely fine with that too. A more honest category is the thing we actually want.

See the Fodease label and full activity units →

Dr. Aron reviewed this article for scientific accuracy. She is not affiliated with Fodease and does not endorse any product.

---

References

1. Baijal R, Tandon RK. Effect of lactase on symptoms and hydrogen breath levels in lactose intolerance: a crossover placebo-controlled study. JGH Open. 2021;5(1):143-148. Link
2. Mysonhimer AR, et al. Bifidobacterium animalis subsp. lactis Bi-07 supports lactose digestion in vitro and in randomized, placebo- and lactase-controlled clinical trials (Booster Alpha, NCT03659747; Booster Omega, NCT03814668). Nutrients. 2022;14(24):5274. Link
3. Di Stefano M, Miceli E, Gotti S, Missanelli A, Mazzocchi S, Corazza GR. The effect of oral alpha-galactosidase on intestinal gas production and gas-related symptoms. Dig Dis Sci. 2007;52(1):78-83. Link
4. Tuck CJ, Taylor KM, Gibson PR, Barrett JS, Muir JG. Increasing symptoms in irritable bowel symptoms with ingestion of galacto-oligosaccharides are mitigated by alpha-galactosidase treatment. Am J Gastroenterol. 2018;113(1):124-134. Link
5. Böhn L, et al. A randomized double-blind placebo-controlled crossover pilot study: acute effects of the enzyme alpha-galactosidase on gastrointestinal symptoms in irritable bowel syndrome patients. Neurogastroenterol Motil. 2021. Link
6. Hillilä M, Färkkilä MA, Sipponen T, Rajala J, Koskenpato J. Does oral alpha-galactosidase relieve irritable bowel symptoms? Scand J Gastroenterol. 2016;51(1):16-21. Link
7. Castro Ochoa K, et al. In-vitro efficacy of targeted FODMAP enzymatic digestion in a high-fidelity simulated gastrointestinal environment. Gastro Hep Advances. 2023;2(3). (Industry-funded.) Link
8. Guice JL, Hollins MD, Farmar JG, Tinker KM, Garvey SM. Microbial inulinase promotes fructan hydrolysis under simulated gastric conditions. Front Nutr. 2023;10:1129329. (Industry-funded, enzyme ingredient supplier.) Link
9. Kaye, et al. Gastro Hep Advances. 2026;5(4). Single-arm, open-label survey study of FODMAP enzyme users. (Industry-funded.)
10. Biochemistry, Polyol Or Sorbitol Pathways. StatPearls. Link
11. Komericki P, Akkilic-Materna M, Strimitzer T, Weyermair K, Hammer HF, Aberer W. Oral xylose isomerase decreases breath hydrogen excretion and improves gastrointestinal symptoms in fructose malabsorption: a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2012;36(10):980-987. Link